Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma

Molecular Medicine

Volumn 20, Issue 1, 2014, Pages 164-178

  Ren, Jin ^a   Wang, Rui ^a   Song, Haizhu ^a   Huang, Guichun ^a   Chen, Longbang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; AZACITIDINE; BRIDGED COMPOUNDS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SULFONAMIDES; TAXOIDS; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84898448334     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00149     Document Type: Article

References (47)

1. Parkin DM, Bray F, Ferlay J, Pisani P. (2005) Global cancer statistics, 2002. CA. Cancer J. Clin. 55:74-108.
2. Jemal A, et al. (2008) Cancer statistics, 2008. CA. Cancer J. Clin. 58:71-96.
3. Yvon AM, Wadsworth P, Jordan MA. (1999) Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell. 10:947-59.
4. Wang TH, Wang HS, Soong YK. (2000) Paclitaxelinduced cell death: where the cell cycle and apoptosis come together. Cancer. 88:2619-28.
5. Ramachandran K, et al. (2009) Methylationmediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target. Cancer Res. 69:1527-35.
6. Jin B, Robertson KD. (2013) DNA methyltransferases, DNA damage repair, and cancer. Adv. Exp. Med. Biol. 754:3-29.
7. Gordian E, Ramachandran K, Singal R. (2009) Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity. Anticancer Res. 29:3207-10.
8. Dennis S, Aikawa M, Szeto W, d'Amore PA, Papkoff J. (1999) A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates wnt-1 signaling. J. Cell Sci. 112(Pt 21):3815-20.
9. Uren A, et al. (2000) Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol. Chem. 275:4374-82.
10. Caldwell GM, et al. (2004) The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 64:883-8.
11. Fukui T, et al. (2005) Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene. 24:6323-7.
12. Veeck J, et al. (2006) Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene. 25:3479-88.
13. Zhang YW, et al. (2010) Transcriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancer. Neoplasma. 57:228-33.
14. Feng B, Wang R, Song HZ, Chen LB. (2012) MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer. 118:3365-76.
15. Wang R, Zhang YW, Chen LB. (2010) Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinoma. Lung Cancer. 69:239-44.
16. Dumontet C, Jordan MA, Lee FF. (2009) Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies. Mol. Cancer Ther. 8:17-25.
17. Baird RD, Kaye SB. (2003) Drug resistance reversal-are we getting closer? Eur. J. Cancer. 39:2450-61.
18. Wang R, Huang J, Feng B, De W, Chen L. (2012) Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma. Mol. Med. 18:874-86.
19. Kastl L, Brown I, Schofield AC. (2010) Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells. Int. J. Oncol. 36:1235-41.
20. Boren T, et al. (2009) MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol. Oncol. 113:249-55.
21. Rui W, Bing F, Hai-Zhu S, Wei D, Long-Bang C. (2010) Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). J. Cell. Mol. Med. 14:206-14.
22. Feng B, Wang R, Chen LB. (2012) MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Cancer Lett. 317:184-91.
23. Cortes-Sempere M, et al. (2013) IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. Oncogene. 32:1274-83.
24. Mattern J, Eichhorn U, Kaina B, Volm M. (1998) O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int. J. Cancer. 77:919-22.
25. Gil EY, et al. (2012) Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer. Int. J. Oncol. 41:611-20.
26. Wang N, et al. (2012) TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer. J. Exp. Clin. Cancer Res. 31:6.
27. Kawano Y, Kypta R. (2003) Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116:2627-34.
28. Saran U, Arfuso F, Zeps N, Dharmarajan A. (2012) Secreted Frizzled-Related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers. BMC Cell. Biol. 13:25.
29. Su HY, et al. (2010) Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int. J. Cancer. 127:555-67.
30. Takada T, et al. (2004) Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci. 95:741-4.
31. Gauger KJ, Chenausky KL, Murray ME, Schneider SS. (2011) SFRP1 reduction results in an increased sensitivity to TGF-beta signaling. BMC Cancer. 11:59.
32. Jiang GX, et al. (2010) Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma. Dig. Dis. Sci. 55:2838-43.
33. Hu J, et al. (2009) Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res. 69:6951-9.
34. Pode-Shakked N, et al. (2011) Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target. Oncogene. 30:1664-80.
35. Cooper SJ, et al. (2012) Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol. Cancer Ther. 11:2105-15.
36. Alfieri CM, Cheek J, Chakraborty S, Yutzey KE. (2010) Wnt signaling in heart valve development and osteogenic gene induction. Dev. Biol. 338:127-35.
37. Hu M, et al. (2007) Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology. 133:1579-91.
38. Inagawa S, et al. (2002) Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin. Cancer Res. 8:450-6.
39. Cagatay T, Ozturk M. (2002) P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Oncogene. 21:7971-80.
40. Noda T, et al. (2009) Activation of Wnt/betacatenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma. Br. J. Cancer. 100:1647-58.
41. Bjorklund CC, et al. (2011) Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide. J. Biol. Chem. 286:11009-20.
42. Liao DJ, Thakur A, Wu J, Biliran H, Sarkar FH. (2007) Perspectives on c-Myc, cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Crit. Rev. Oncog. 13:93-158.
43. Kajiyama H, et al. (2007) Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int. J. Oncol. 31:277-83.
44. Jeays-Ward K, et al. (2003) Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development. 130:3663-70.
45. Yook JI, et al. (2006) A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell. Biol. 8:1398-406.
46. Gavert N, Ben-Ze'ev A. (2008) Epithelialmesenchymal transition and the invasive potential of tumors. Trends Mol. Med. 14:199-209.
47. Ren J, Chen Y, Song H, Chen L, Wang R. (2013) Inhibition of ZEB1 reverses the phenotype of epithelial-mesenchymal transition and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line SPC-A1/DTX. J. Cell. Biochem. 114:1395-403.